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Abstract
Aminoacyl tRNA synthetases play a central role in protein synthesis by charging tRNAs with amino acids. Yeast
mitochondrial lysyl tRNA synthetase (Msk1), in addition to the aminoacylation of mitochondrial tRNA, also functions as a
chaperone to facilitate the import of cytosolic lysyl tRNA. In this report, we show that human mitochondrial Kars (lysyl tRNA
synthetase) can complement the growth defect associated with the loss of yeast Msk1 and can additionally facilitate the in
vitro import of tRNA into mitochondria. Surprisingly, the import of lysyl tRNA can occur independent of Msk1 in vivo. This
suggests that an alternative mechanism is present for the import of lysyl tRNA in yeast.
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Introduction
Aminoacyl-tRNA synthetases are a heterogeneous family of
enzymes responsible for aminoacylating tRNAs with the appro-
priate amino acids. The budding yeast, Saccharomyces cerevisiae,
contains two sets of lysyl-tRNA synthetases (Msk1 and Krs1) that
are encoded by nuclear DNA. Krs1 participates in cytoplasmic
protein synthesis while Msk1 in mitochondrial protein synthesis.
Despite the structures of the Msk1 and Krs1 being different,
functionally they are very similar. The yeast Msk1 has a bacterial
ancestry, whereas the Krs1 represents the ancestral eukaryotic
type [1,2].
Yeast Msk1 is a dual functional protein. In addition to
aminoacylation of mitochondrial tRNA
Lys (tRK3), it has been
proposed that Msk1 plays an essential role in the import of
cytosolic tRNA
Lys
CUU (tRK1) into mitochondria [3]. There are
two other lysine isoacceptors in yeast cells: the non-imported
nuclear encoded tRNA
Lys
UUU (tRK2) and the mitochondrial DNA
encoded tRNA
Lys
UUU (tRK3) [4]. Further, the imported tRK1
that was specifically mutagenized to alter amino acid specificity
was functional in yeast mitochondrial translation both in vivo and in
vitro [5]. However, for tRK1 to be eligible for mitochondrial
import, it has to go through a complex set of reactions that
includes aminoacylation of tRK1 by cytosolic lysyl-tRNA
synthetase, interaction of tRK1 with glycolytic enzyme enolase 2
(Eno2) and binding to the precursor form of Msk1 (pre-Msk1)
[3,6,7]. The subsequent translocation across the mitochondrial
membranes requires intact protein import machinery and ATP
[3,8]. The function of the imported tRNA is conditional and its
import is also regulated by ubiquitin/26S proteosome [9,10].
Further, the translocation across the mitochondrial membranes
requires intact protein import machinery, ATP and additional un-
identified cytosolic factors. However, the charged tRK1 imported
into mitochondria by the pre-Msk1p mediated mechanism is only
utilized in one cycle of translation as it cannot be re-charged by
Msk1. The utilization of tRK1 in mitochondria is dependent on
continuous action of cytosolic and mitochondrial tRNA synthe-
tases. Hence the utilization of imported tRK1 is limited by the
activity and availability of these two synthetases besides its function
being restricted to one round of translation.
Yeast tRK1 can also be imported into human mitochondria in
the presence of yeast cytosolic factors and Msk1 [5]. In addition,
human cytosolic factors can replace yeast cytosolic factors in the
presence of Msk1 to drive the import of tRK1 into human
mitochondria [5]. It was previously suggested that human Kars
might play a similar kind of role in the import of tRK1 into
mitochondria [11]. However, there was no direct evidence
showing that human Kars is indeed involved in the import of
tRK1 into either human or yeast mitochondria.
We previously have shown that human mitochondrial and
cytoplasmic lysyl tRNA-synthetases are expressed from alternative
spliced mRNAs from a single gene [12]. We are interested to see
whether human mitochondrial tRNA synthetase mitigates the role
of yeast tRNA synthetases in the import and aminoacylation of
tRK1 since the evolution and structural relatedness of these
enzymes has been a subject of intense research for many years.
Unlike yeast synthetases, both human cytosolic and mitochondrial
lysyl-tRNA synthetases (Kars) are capable of aminoacylating yeast
tRK1. Human mitochondrial Kars can substitute for yeast Msk1
for protein synthesis and tRNA import functions. Further, our
findings suggest that human Kars facilitates the import of tRK1
into isolated yeast, rat and human mitochondria. In addition,
human KARS partially suppresses the growth defects that are
associated with yeast MSK1 deletion. Interestingly, in vivo
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is independent of yeast Msk1.
Results
Human mitochondrial lysyl-tRNA synthetase suppresses
the growth defect associated with yeast MSK1 deletion
Yeast cells deleted for MSK1 do not grow on non-fermentable
carbon sources as they are unable to aminoacylate mitochondrial
tRNA
Lys (tRK3). This results in the inhibition of mitochondrial
protein synthesis and loss of mtDNA. Before investigating the
ability of human Kars to import tRK1 into yeast mitochondria, we
determined whether Kars could substitute for the yeast Msk1 in
the aminoacylation of tRK3. To test this, we introduced the
human KARS cDNA or yeast MSK1 on a high/low copy plasmids
into a yeast strain heterozygously deleted for MSK1 by insertion of
a KANMX4 cassette (NS104). The resulting yeast strains were
sporulated on fermentable and nonfermentable carbon containing
media plates. In initial tests, all four meiotic progeny from diploid
strains that contained high copy yeast MSK1 formed colonies on
both fermentable and non-fermentable carbon sources. Progeny
from the diploid strain that contained high copy human KARS
plasmid yielded four spores on fermentable and nonfermentable
carbon sources. Out of the four spores, two were larger and wild
type for MSK1 gene while other two were smaller and positive for
MSK1 deletion (data not shown). Haploid progeny with KARS on a
low copy plasmid failed to grow on non-fermentable carbon
sources (data not shown). These results suggest that human KARS
can substitute yeast MSK1 deletion partially.
We investigated further the growth properties of the haploid
progeny of strain NS104 containing high copy plasmids expressing
human mitochondrial KARS or yeast MSK1 under respiring and
fermenting conditions. Cells were grown at 30uC in selective
medium, serially diluted and spotted on rich carbon sources
(YEPD) and on non-fermentable carbon sources (YEP plates
supplemented with 3% glycerol/ethanol). Cells expressing high
levels of human KARS partially suppressed the growth defect of
msk1D cells on both fermentable and on non-fermentable carbon
sources (Figure 1). The extent of suppression was comparable to
that achieved by high levels of ectopically expressed MSK1. Cells
deleted for MSK1 exhibited poor growth on rich carbon sources
compared to cells wild type for MSK1 (NS101; Figure 1). The
reason for the slow growth of the msk1D strain on rich carbon
sources is not known, but it could be strain specific. However, loss
of MSK1 displayed a similar phenotype on non-fermentable
carbon sources in other strain backgrounds ([3], present study).
Further, human KARS poorly complements the growth defect at
37uC caused by MSK1 deletion (unpublished results). This may be
due to requirement of Msk1 at elevated temperature for the import
of tRK1 [9].
Nevertheless, the results show that human KARS partially
complements yeast MSK1 deletion. We hypothesize that the
human Kars can be imported into yeast mitochondria and
substitute the function of yeast Msk1.
Recombinant human mitochondrial lysyl-tRNA
synthetase directs the import of tRK1 into yeast
mitochondria
We used an in vitro import system with bacterially expressed
human Kars to investigate whether human Kars can import tRK1
into yeast mitochondria. Yeast mitochondria isolated from strain
D273-10B [13] and were incubated with in vitro transcribed [
32P]-
labeled tRK1 under standard import conditions and the import
efficiency was determined by RNase protection assay. tRK1 was
imported into yeast mitochondria in the presence of wild-type
yeast cytosol (Figure 2A, lane 1). Yeast cytosol is expected to
contain both the cytosolic lysyl-tRNA synthetase and trace
amounts of pre-Msk that are required for tRK1 import [3].
tRK1 was not imported into yeast mitochondria in the presence of
a yeast cytosolic extract derived from a msk1D strain (Figure 2A,
lane 2). However, the addition of purified human Kars (Figure 2A,
lanes 6 and 7) or yeast Msk1 (Figure 2A, lanes 3–5) resulted in
import of tRK1 into yeast mitochondria. A dose dependent
increase in the import of tRK1 into yeast mitochondria was
observed with increasing concentrations of added human Kars
(Figure 2A, lanes 6 and 7). tRK1 was not imported into yeast
mitochondria in the presence of yeast Msk1 or human Kars alone
(data not shown). Similar results were obtained when yeast
mitochondria substituted with mitochondria isolated from rat liver
or human 143b cells (Figures 2B and 2C). These results show that
human Kars can substitute for yeast Msk1 in targeting tRK1 into
mitochondria in vitro in the presence of cytosol.
Human cytosol can complement yeast cytosol in the
import of tRK1 into yeast or mammalian mitochondria
Cytosolic extract from human cells was used to investigate
whether human cytosol can complement the yeast cytosol in
directing the import of tRK1 into mammalian and yeast
mitochondria. Isolated mitochondria from human 143b cells, rat
liver or yeast were incubated with
32P labeled ATP and processed
as described in Methods. tRK1 was not imported into mitochon-
dria in the absence of yeast or human cytosol (Figure 2D).
Addition of mammalian cytosol to the reaction stimulated the
import of tRK1 into human, rat liver or yeast mitochondria
(Figure 2D). Cytosolic extract from a MSK1 deletion strain failed to
import the tRK1 either into yeast or mammalian mitochondria
but the addition of purified human Kars or yeast Msk1 stimulated
the import of tRK1 into mitochondria. These results show that
human Kars or yeast Msk1 are equally efficient in stimulating the
import of tRK1 and that human cytosol can substitute the role of
yeast cytosol in directing the import of tRK1 into mitochondria in
vitro.
In vivo distribution of tRK1
Next, we analyzed the distribution of tRK1 in wild type and
MSK1 deletion strains. High resolution northern blot analysis
suggested that more than 95% of the tRK1 is associated with
Figure 1. Suppression of growth defect associated with yeast
MSK1 deletion by human mitochondrial lysyl-tRNA synthetase.
Strains carrying various ectopic plasmids were grown on YEPD medium
over night. 2 0D600 unit cells were pelleted and suspended in 1 ml of
water. The culture was serially diluted in 10-fold steps and 10 ul of each
dilution was spotted onto YEPD and YEG plates. Two lanes of D/
hmtKARS represent two spores originated from the single tetrad.
doi:10.1371/journal.pone.0035321.g001
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wild-type cells (data not shown), consistent with previous studies
[14]. Earlier studies showed the absence of tRK1 in the
mitochondria of msk1D strain [3]. However, in our preliminary
studies, a small but significant amount of tRK1 was associated
with mitochondria in the msk1D strain (data not shown).
The association of tRK1 with mitochondria isolated from msk1D
cells could be due to contamination of mitochondria preparation
with cytosol. Loss of mitochondrial DNA as a result of MSK1
deletion could change the mitochondrial morphology and result in
enhanced association with the cytosolic fraction. However, we
have observed decreased levels of mitochondrial-associated tRK1
in a rho
0 strain that was generated by ethidium bromide treatment
of parental strain NS101 (data not shown). To determine whether
tRK1 was localized inside mitochondria or is a cytosolic
contaminant, we used several methods that could eliminate
cytosolic contamination with little reduction in the endogenous
mitochondrial tRNA levels. First, we selectively permeabilized the
mitochondrial membranes by digitonin detergent. Low concen-
trations of digitonin disrupt and partially solubilize the outer
mitochondrial membrane as well as removing other membranous
structures contaminating the mitochondrial fraction. To determine
the concentration of digitonin that is required to reduce the
cytosolic contamination, aliquots of mitochondria were treated
with increasing concentrations of digitonin prior to centrifugation.
Initially, the pellet and supernatant fractions were analyzed for the
selective solubilization of specific proteins that serve as markers for
the different mitochondrial subfractions. In subsequent experi-
ments, nucleic acids were isolated from the digitonin soluble
supernatant and insoluble pellet fractions and specific tRNA
species were detected and quantitated by northern analysis.
Treatment of mitochondria with 0.05% digitonin solubilized
specifically the mitochondrial outer membrane, as shown by the
release of the intermembrane space marker protein, CCPO into
the supernatant (Figure 3A). Higher concentrations of digitonin
solubilized the mitochondrial inner membrane, shown by the
release into the supernatant of the matrix marker protein Put2 and
the inner membrane protein Tim23 (Figure 3A). Endogenous
tRK3 and imported tRK1 were released into the supernatant at
the same concentrations of digitonin, which released the matrix
protein Put2 (compare Figures 3A and 3B). These results indicate
that mitochondrial membranes are intact and that the imported
tRK1 fragments are found in the same intramitochondrial fraction
as the endogenous mtDNA-encoded tRNA, tRK3. The levels of
Figure 2. Import of tRK1 into yeast (Fig. 2A), rat liver (Fig. 2B) and human mitochondria (Fig. 2C) in the presence of human
mitochondrial lysyl-tRNA synthetase. Import of tRK1 into isolated yeast or mammalian mitochondria was performed in the presence or absence
(lane 2) of either yeast or human mitochondrial lysyl-tRNA synthetase (lanes 3–7). The import efficiency was assessed by RNase protection assay
followed by polyacrylamide gel electrophoresis and phosphorimaging. Lane 1 contains wild type yeast cytosol that presumably contains both
cytosolic and mitochondrial lysyl- tRNA synthetase. Fig. 2D. Substitution of yeast cytosol with human cytosol for the import of tRK1 into either yeast
or mammalian mitochondria. Import of tRK1 was carried out into yeast (lanes 1, 2, 4 & 9) and human mitochondria (lanes 3, 5, 6, 7 & 8) in the presence
of wild type yeast cytosol (lanes 2 & 3), or mskD cytosol (lanes 4, 7 & 8) or human cytosol (lanes 5, 8 & 9). The import efficiency was assessed by RNase
protection assay followed by electrophoresis. The bands were quantified and relative tRK1 import values were mentioned by taking maximum
imported sample as a value of 1.
doi:10.1371/journal.pone.0035321.g002
tRNA Import into Mitochondria
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e35321tRK2, a non-imported cytosolic tRNA, are reduced by 60–70%
compared to the untreated mitochondria at 0.075% concentration
(Figure 3B). It appears that digitonin resistant structures are still
associated with nonspecific cytosolic tRNAs.
We determined if treatment of mitochondria with MNase
(Micrococcal Nuclease) would reduce the contamination of
cytosolic tRNAs. However, mitochondria treated with MNase
alone showed contamination of cytosolic RNAs as evidenced by
the presence of tRK2 (Figure 3D, lanes 2–4). We therefore
developed alternative approach in which we treated mitochondria
with increased concentrations of digitonin and fixed concentration
of MNase or fixed concentration of digitonin and increasing
concentrations of MNase to reduce non-specific association of
cytosolic RNAs. It was previously shown that nuclear encoded
small RNAs non-specifically associated with highly purified
mitochondrial preparations but were sensitive to digitonin and
MNase treatment [15].
In the first approach, mitochondria were treated with increasing
concentrations of digitonin (Figure 3C, lanes 2–4) and then with a
fixed concentration of MNase (Figure 3C, lanes 6–8). Aliquots of
mitochondria were treated with increasing concentrations of
digitonin (0–0.2%) for 15 minutes on ice. Mitochondria were re-
isolated and treated with MNase at 500 U/ml for 25 minutes on
ice and processed as described in the Methods. As shown in the
figure 3C, low concentrations of digitonin (lanes 1–3) failed to
reduce the cytosolic RNA contamination whereas the higher
concentrations completely eliminates the cytosolic RNA levels but
also reduces the endogenous tRNA levels significantly (Figure 3C,
lane 4).
In another approach, aliquots of mitochondria were incubated
with 0.05% digitonin to solubilize the outer membrane and then
treated with different concentrations of MNase for 25 minutes on
ice. Total nucleic acids were isolated and the presence of various
tRNAs was detected by northern blot using specific probes. The
Figure 3. In vivo distribution of tRK1 in yeast cells. Isolated mitochondrial preparations were subjected to increasing concentrations of
digitonin (Fig. 3A & B). Digitonin soluble (sup) and insoluble fractions (pellet) were separated by centrifugation. One set was used to analyze protein
markers of outer membrane (porin), inter membrane space (CCPO), inner membrane (Tim 23) and the matrix (Put2) by SDS-PAGE followed by western
blot (3A). In parallel, the other fraction was used to extract total RNAs and analyzed by northern blot for the presence of tRK1, tRK2 and tRK3 by using
specific oligonucleotide probes. Isolated yeast mitochondrial preparations were treated with increasing concentration of digitonin from 0–0.2% (Fig.
3C) or 0.05% of digitonin (Fig. 3D) for 20 min on ice and reisolated the mitochondria by centrifugation. The pellet fraction was either treated with
250–750 units of MN (Fig. 3D) or 500 units of MN (Fig. 3C, lanes 5–8). Total RNA was extracted and analyzed by northern blot as above. Standard is the
respective in vitro transcribed unlabeled tRNA that was used as a positive control except in the case of tCys and tPhe (Fig. 3C). Cytosolic fraction
represents 2 mg of total RNA from the cytosol to show the levels of various tRNAs (Fig. 3C).
doi:10.1371/journal.pone.0035321.g003
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almost completely eliminated by treatment of the mitochondrial
fraction with 0.05% digitonin and MNase (Figure 3D, lanes 5–8).
This treatment had little effect on the amount of mitochondrial
tRNA (represented by tRK3, Figure 3), even at the highest
concentration of MNase.
The above experiments showed that neither digitonin nor
MNase treatment alone was sufficient to remove the contaminat-
ing cytosolic tRNAs. However, we could reduce the amount of
contaminating cytosolic RNAs by 97–99% without greatly
reducing the endogenous RNA levels by a combined treatment
of the mitochondrial fractions with digitonin and MNase. We used
this combined treatment to further investigate import of tRK1 into
yeast mitochondria.
Import of tRK1 in yeast cells is independent of Msk1
To further investigate whether isolated mitochondria from
msk1D strain contained any significant amounts of tRK1, we used
the combined digitonin and MNase treatment described above to
analyze the tRNAs associated with mitochondria. Mitochondria
isolated from wild type and msk1D cells were treated with 0.05%
digitonin for 30 minutes on ice, re-isolated, and treated with
MNase at 500 U/ml for 25 minutes on ice. Total mitochondrial
nucleic acids were then extracted and separated by urea-
acrylamide gel electrophoresis and examined for the presence of
representative cytosolic tRNAs (tRK1, tRK2, tRNA
Cys, tRNA
Phe)
by northern analysis (Figure 4A). In the absence of digitonin and
MNase treatment, as expected, a small portion of the cytosolic
tRNAs are associated with mitochondria isolated from wild type
and msk1D strains (Figure 4A, lanes 3 and 5). Treatment of
mitochondria with digitonin and MNase reduced the level of most
cytosolic tRNAs (tRK2, tRNA
Cys, tRNA
Phe). However, the
amount of tRK1 is at least 10-fold greater than other cytosolic
tRNAs, in both wild type and msk1D mitochondria (Figure 4A,
lanes 4 and 6; Figure 4B). In mitochondria isolated from msk1D,
the amount of tRK1 is decreased by 50% but its inaccessibility to
digitonin and MN treatment (Figure 4A, lane 6) indicates that
tRK1 is imported in these cells, despite the lack of Msk1. Results
from three independent experiments suggest that tRK1 can be
imported into mitochondria in the absence of Msk1 (Figure 4B).
We excluded the possibility that the MSK1 gene was not deleted
or partially deleted in our commercially obtained msk1D strain, by
PCR analysis. We isolated total genomic DNA from the parent
and from the msk1D strain and performed PCR with primers
flanking the open reading frame of MSK1. The putative msk1D
strain contained the larger KanMX4 marker gene as the entire
coding region of MSK1 is replaced (Figure 5, lanes 1 and 2). We
also used primers annealing to regions within the MSK1 gene. As
expected, MSK1 gene product was obtained from the parent strain;
no product was amplified from the msk1D strain (Figure 5, lanes 3
and 4). This analysis confirmed that msk1D cells indeed lacked the
MSK1 gene. We conclude that yeast mitochondrial lysyl-tRNA
synthetase does not play a significant role in the import of native
tRK1 into the mitochondrial matrix.
Discussion
Yeast Msk1 is a dual functional protein, it aminoacylates the
tRNA
Lys (tRK3) of mitochondria, and is also involved in the
import of tRK1 into mitochondria [3]. We show here that human
mitochondrial lysyl tRNA-synthetase (KARS) cDNA, when present
in multiple copies, partially rescues the growth defect of msk1D
cells on non-fermentable carbon sources. We also show that
human Kars imports tRK1 into isolated yeast and mammalian
mitochondria in the presence of yeast or human cytosolic factors.
Our results provide genetic and biochemical evidence that human
Kars can perform the role of yeast Msk1. The results presented
here demonstrate for the first time that purified recombinant
human Kars could complement the role of yeast Msk1 in the
import tRK1 into isolated yeast mitochondria or into mammalian
mitochondria in vitro.
It had been proposed that interaction between tRK1 and pre-
Msk1 is absolutely essential for the import of tRK1 into
mitochondria, since no tRK1 was detected in mitochondria from
msk1D yeast cells [3]. However, we observe only slightly decreased
levels of tRK1 in mitochondria from msk1D strain when compared
to tRK1 levels in mitochondria isolated from a isogenic wild type
strain. We show that association of tRK1 with mitochondria
isolated from the msk1D strain is not due to non-specific
contamination of cytosolic fraction. tRK1 is still detected in
mitochondria isolated from msk1D strain and the mitochondria
had been incubated with digitonin and MNase (Figure 3). It is
clear from our results that the pre-Msk1 is not essential for import
of tRK1 into mitochondria from the cytoplasm in vivo. Our results
differ from a previous study [3] and this difference could be due to
several reasons. The possibilities include a) a different strain
background b) incomplete deletion of MSK1 and c) different
techniques to detect tRNAs. We employed high-resolution
northern blot hybridization to detect mitochondrial tRNAs,
whereas dot-blot hybridization method was used in previous
studies which may not detect small quantities of tRNAs that are
associated with mitochondria [3]. We also show that our msk1D
strain lacks the MSK1 gene by genomic PCR. However, we cannot
rule out the possibility that the association of tRK1 in
mitochondria isolated from msk1D strain is strain specific.
Our studies suggest that the in vivo import of tRK1 occurs
independently of mitochondrial lysyl-tRNA synthetase. However,
we observe that the import of tRK1 into mitochondria requires the
presence of Msk1 in vitro. The in vitro import of tRK1 differs from
other well-established systems in the requirement of many factors.
Cytosolic factors are not required for the import of tRNAs into
mitochondria of Tetrahymena [16], or in Trypanosoma [17] or in
Leishmania [18] or in plants [19]. Nevertheless, it has been shown
that aminoacylation is essential for the import of tRNA
Ala into
Arabidopsis thaliana mitochondria. This evidence suggested that
amino acyl-tRNA synthetases are indeed involved in the import of
tRNAs into plant mitochondria [20]. However, the over-
expression of A. thaliana alanyl-tRNA synthetase in yeast cells
was not sufficient to import its cognate tRNA
Ala into the yeast
mitochondria [21], indicating that the mechanism of import is
different from plants to yeast. In yeast, aminoacylated tRK1 is
essential for import, however, it is being utilized only once in the
mitochondrial translation as Msk1 does not aminoacylate the
cytosolic tRK1. The necessity of this conditional import of this
tRNA into mitochondria could be a non-essential function of
aminoacylated tRNA in mitochondrial translation as mitochon-
drial encoded tRK3 can decode both AAA and AAG codons.
However, the imported aminoacylated tRK1 plays an important
role at elevated temperature in decoding AAG codons as
mitochondrial tRK3 is defective [9]. Recently, it has been shown
that cytosolic Gln-tRNA is imported into yeast mitochondria and
its import is independent of cytosolic factors and yeast mitochon-
drial Gln tRNA synthetase [22].
Cytosolic factors are essential as Msk1 is required for the import
of tRK1 into isolated yeast mitochondria in vitro. The precise role
of cytosolic factors in the import of tRK1 into mitochondria is not
known. It was speculated that probably the cytosolic factors act to
stabilize the pre-Msk/tRK1 complex or facilitate the binding of
tRNA Import into Mitochondria
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existence of an import mechanism for the import of tRK1 that is
not dependent on Msk1.
The import of precursor proteins or tRNA into mitochondria
requires one or more outer membrane receptors [24]. It was
observed that mitochondria can import preproteins with reduced
efficiency when the cytosolic domains of the import receptors were
removed by trypsin treatment. This residual import is called
bypass import [25,26]. It is possible that the import of tRK1 can
be accomplished without the presence of Msk1 by alternative
methods in vivo. In support of this hypothesis, we find reduced
levels of tRK1 in mitochondria isolated from a msk1D strain when
compared to the parental strain. We have also observed that
cytosolic factors alone when present in large quantities, slightly
stimulates the import of tRK1 into isolated yeast mitochondria in
the absence of Msk1 in vitro (unpublished results). Our findings
indicate that the in vivo import of tRK1 differs from the in vitro
import. Our results also suggest that alternative import pathways
are present for tRNA import and yeast can serve as a model




BY4741 (MATa/MATa his3D1 leu2D0 met15D0 ura3D0),
BY4742 (MATa his3D1 leu2D0 lys2D0 ura3D) and msk1D (MATa
msk::KAN his3D1 leu2D0 met15D0 ura3D0) strains were obtained
from Research Genetics Inc. Heterozygous diploid strain NS104
(MATa/MATa his3D1/his3D1 leu2D0/leu2D0 met15D/MET
ura3D0/ura3D0 LYS/lys2D0) was constructed by crossing strain
BY4742 with msk1D. Strain NS108 is isogenic to NS104 but
contains MSK1 on a high copy plasmid (pTEF MSK1 URA3-2m).
Strain NS112 (MATa his3D1 leu2D0 met15D0 ura3D0) contains
human KARS on URA3-2m plasmid. Standard yeast genetics and
techniques were used [27].
Plasmids and cloning
The complete coding sequence of human mitochondrial lysyl-
tRNA synthetase (KARS) cDNA was amplified by PCR using
Thermo polymerase (Ambion) with KARS-A primer (ACTAGT-
GAATTCATGTTGACGCAAGCTGCT) containing an EcoRI
site and KARS-B primer (GGATCGATCTCGAGGACA-
Figure 4. Presence of tRK1 in msk1D mitochondria. Mitochondria isolated from wild type or msk1D strains were treated with digitonin and
MNase and total nucleic acids were separated on urea-acrylamide gel and analyzed by northern blot with respective probes. Total RNA represents the
total cell RNA (2 mg) that was used to determine the levels of various tRNAs in the cytosol (Fig. 4A). Figure 4B represents the quantification of band
intensities by densitometry.
doi:10.1371/journal.pone.0035321.g004
Figure 5. Confirmation of MSK1 deletion in yeast strain by PCR
analysis. Analytical PCR was performed with isolated genomic DNA
from wild type and msk1D strain by using internal and upstream
primers to detect the loss of msk1 as mentioned in the Methods
Section. Lane 1 represents the wt MSK1 gene, lane 2 represents the KAN
marker at MSK1 locus, lane 3 represents the internal fragment
generated by using internal primer in wild type and lane 4 represents
the lack of MSK1 gene in msk1D strain.
doi:10.1371/journal.pone.0035321.g005
tRNA Import into Mitochondria
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35321GAAGTGCCAACTGT) containing a XhoI site. Human KARS
and was cloned into the pGEM-T Easy vector to generate plasmid
pNS33. pNS33 was digested with EcoRI and XhoI and the KARS
ORF was isolated and cloned into a 2m vector (pTEF-URA3)a t
EcoRI and XhoI sites [28] (a kind gift from Erica Johnson, TJU) to
generate pNS37. MSK1 was amplified using yeast genomic DNA
as a template and primers MSK1-A (GGCACGTGACTAG-
TATGAATGTGCTGTTAAAA) and MSK1-B (GGATCGA-
TAAGCTTTTACTGCCTGTTTACATC) and the PCR prod-
uct was cloned into pGEM-T Easy vector to create pNS32. A
SpeI/HindIII digestion product of pNS32 containing MSK1 was
inserted into pTEF-URA to generate pNS34. PCR was performed
to check the insertion of KAN marker at MSK1 locus with sense
primer MSK1-C (TAGTCTTTTATTCGTGATAAAAGC-
GAAAAT) and antisense primer MSK1-D (CGTAGCGTAGTT-
TATTGGTGTAGAGAAAAA). To exclude the possibility of
partial deletion of MSK1 gene, PCR was performed with sense
primer MSK1-C (TAGTCTTTTATTCGTGAAAAAAGC-
GAAAAT) and antisense primer MSK1-E (AATACGCAACTC-
CAAATGGTCGAAGTC CTT).
Over expression and purification of human and yeast
mitochondrial lysyl-tRNA synthetases
The human mitochondrial lysyl-tRNA synthetase cDNA cloned
in pET 24d vector (Novagen) was expressed in E. coli BL21 (DE3)
Codon Plus (RIL) cells and purified to 80% homogeneity as
described [12]. The complete coding sequence of yeast mitochon-
drial lysyl-tRNA synthetase (MSK1) was PCR amplified and cloned
into E. coli expression vector pET24d to generate a hexahistidine
tag at the carboxyl terminal of synthetase. This construct was
expressed in E. coli BL21 (DE3) Codon Plus (RIL) (Stratagene) at
15uC for 12 hours in the presence of 0.5 mM isopropyl-1-thio-b-
D-galactopyranoside. The histidine tagged soluble pre-protein was
partially purified using Talon metal affinity resin (Clontech) and
concentrated. The purified Msk constituted approximately 70% of
the total purified protein.
Preparation of tRNA substrate and end labeling
A synthetic gene encoding tRK1 downstream from a T7
polymerase promoter was constructed by annealing ten overlap-
ping oligonucleotides and cloning into EcoRI/BamHI digested
pUC19 vector. This plasmid was linearized with Bst NI and used
as a template for in vitro transcription using T7 polymerase. The
tRK1 in vitro transcript was gel purified and stored in TE pH 8.0.
tRK1 was labeled with a-[
32P]-ATP at the 39 end using E. coli
terminal nucleotidyl transferase as described [29]. Prior to import
assays, the tRNA was denatured at 80uC followed by slow cooling
to 37uC in the presence of 15 mM MgCl2.
Isolation of mitochondria and in vitro import assays
Mitochondria were isolated from yeast [30], rat liver [31] or
from 143b osteosarcoma cell lines [29] as described. Yeast
cytosolic factors were prepared as described [3]. 0.2 pmol of in
vitro synthesized [
32P]-labeled tRK1 was preincubated with 2 mgo f
yeast cytosolic factors with or without purified human Kars or
yeast Msk1 on ice for 10 minutes prior to the import assay. Import
of tRNA into mitochondria was performed in a volume of 100 ml
containing 100 mg of mitochondria, 20 mM HEPES-KOH
pH 7.2, 0.6 M sorbitol, 4 mM ATP, 1 mM GTP, 5 mM MgCl2,
25 mM KCl and 0.2 pmol of [
32P]-labeled tRK1. The import
reaction was carried out at 30uC for 25 minutes. Following
import, mitochondria were re-isolated, suspended in import buffer
and treated with 2.5 mg/ml RNases (Roche Biochemicals) for
30 minutes on ice to remove non-imported tRK1. Then
mitochondria were reisolated and washed three times with SEM
buffer (250 mM Sucrose, 10 mM MOPS pH 7.2, 1 mM EDTA).
The washed mitochondrial pellet was resuspended in 0.1 M
potassium acetate (pH-5.2), 0.5% (w/v) SDS and mitochondrial
RNA was extracted using phenol-chloroform as described [3]. The
total RNA was resolved on 12% urea-polyacrylamide gel
electrophoresis and tRK1 was detected and quantitated by
autoradiography or phosporimaging using a Molecular Dynamics
PhosphorImager. Import of tRNA into isolated rat liver
mitochondria or human cell lines were essentially performed as
described [31]. In brief, isolated mitochondria were incubated
with tRNA in the presence of energy mix at 30uC for 30 minutes
and treated with RNases and processed as above. The Animal
Ethics Committee of the University of Hyderabad approved the
experiment protocol.
Mitoplast Preparation
For generation of mitoplast, digitonin was used to permeabilize
the outer mitochondrial membrane of mitochondria. Mitochon-
dria were suspended at a concentration of 1 mg/ml in SEM
buffer. 250 mg of mitochondria were incubated for 25 minutes on
ice in 250 ml of SEM buffer containing 0 to 0.2% digitonin. The
resulting mitoplasts were harvested by spinning at 14,000 rpm for
10 minutes and the supernatant was saved for further analysis.
The mitochondrial pellet was washed once again with SEM buffer
and was used either for micrococcal nuclease treatment or for the
isolation of mitochondrial nucleic acids. To determine the
efficiency of digitonin treatment, 100 mg of mitochondria were
treated as above with digitonin, centrifuged, and the pellet and
supernatant fractions separated by SDS-PAGE and transferred to
a polyvinylidene difluoride membrane (Immobilon P, Millipore).
Immunoblots were performed using antibodies specific for
cytochrome c peroxidase (CCPO) (intermembrane space),
TIM23 (inner membrane), delta-1-pyrroline-5-carboxylate dehy-
drogenase (Put2p) (matrix) and porin (outer membrane).
Micrococcal Nuclease treatment of Mitochondria
For the Micrococcal nuclease (MNase) treatment, aliquots
(250 mg) of mitochondria were resuspended in 2 mM CaCl2,
250 mM sucrose and 10 mM MOPS pH 7.1. MNase was added
to 500 U/ml unless otherwise specified. MNase treatment was
performed for 25 minutes on ice with occasional mixing. MNase
was then inactivated by the addition of 10 mM EGTA on ice for
5 minutes. The mitochondrial suspension was diluted with SEM
buffer containing 2 mM EGTA and centrifuged at 14000 g for
10 minutes. The reisolated mitochondrial pellet was washed one
more time in SEM buffer. The resulting pellet was used to isolate
total mitochondrial RNA.
Northern blot
Mitochondrial nucleic acids were isolated from the various
samples and were separated on 12% urea-acrylamide gels. The
transfer of nucleic acids to the nylon membranes was performed as
described [29]. Membranes were probed using T4 polynucleotide
kinase-labeled oligonucleotide probes specific for tRK1, tRK2,
tRK3, tRNA
cys and tRNA
Phe. To detect tRK1, we used the
oligonucleotide probe anti tRK1 (GTAGGGGGCTC-
GAACCCCTAACC) for tRK2, the probe anti tRK2
(GCCGAACGCTCTACCAACTCAGC) for tRK3, the probe
anti tRK3 (TAGCTGGAGTTGAACCAAGCATG) for cytosolic
tRNA
cys, the probe anti tRNA
cys (TCAGGATCGAACTAAG-
GACCAAG) and for cytosolic tRNA
Phe, the probe anti tRNA
Phe
(TGAGAATCGAACTACATGTAAAT).
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